Sana Biotechnology, Inc.
SANA
$3.20
-$0.06-1.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -47.21M | -58.83M | -42.15M | -93.80M | -49.39M |
| Total Depreciation and Amortization | 2.39M | 3.05M | 3.19M | 2.86M | 3.65M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.95M | 19.72M | 8.84M | 61.21M | 7.94M |
| Change in Net Operating Assets | -6.51M | 3.41M | 697.00K | -3.37M | -10.86M |
| Cash from Operations | -37.38M | -32.64M | -29.43M | -33.10M | -48.66M |
| Capital Expenditure | -288.00K | -873.00K | -41.00K | 112.00K | -136.00K |
| Sale of Property, Plant, and Equipment | 248.00K | 661.00K | 136.00K | 382.00K | 253.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 49.48M | -16.28M | -48.12M | 7.19M | 16.49M |
| Cash from Investing | 49.44M | -16.50M | -48.03M | 7.68M | 16.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -91.00K | -89.00K | -87.00K | -86.00K | -85.00K |
| Issuance of Common Stock | 59.00K | 17.74M | 109.63M | 587.00K | 1.13M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -96.00K | -- | -- | 60.00K | -60.00K |
| Cash from Financing | -128.00K | 17.65M | 109.54M | 561.00K | 982.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.93M | -31.49M | 32.09M | -24.86M | -31.07M |